Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma

Figure 8

Efficacy assessment of stem cell-associated gene signatures for overall survival prognosis in OV patients. (a) ROC curve analysis of a gene signature in OV patients. (b–f) Time-dependent ROC curves of a gene signature for 1-, 3-, and 5-year overall survival.

(a)

(b)

(c)

(d)

(e)

(f)

(g)